Role of inhibitors of mammalian target of rapamycin in the treatment of luminal breast cancer. [electronic resource]
Producer: 20131029Description: 769-80 p. digitalISSN:- 1473-5741
- Androstadienes -- administration & dosage
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Aromatase Inhibitors -- administration & dosage
- Biomarkers, Tumor -- metabolism
- Breast Neoplasms -- drug therapy
- Disease-Free Survival
- Everolimus
- Female
- Humans
- Molecular Targeted Therapy
- Protein Kinase Inhibitors -- administration & dosage
- Signal Transduction -- drug effects
- Sirolimus -- administration & dosage
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.